InvestorsHub Logo
Followers 28
Posts 2529
Boards Moderated 0
Alias Born 05/08/2015

Re: None

Thursday, 10/07/2021 8:04:22 AM

Thursday, October 07, 2021 8:04:22 AM

Post# of 233151
FOUR MAJOR UPDATES TODAY: CytoDyn Names Chris Recknor, M.D. Senior Executive VP of Clinical Operations to Initiate Two New Clinical Trials for Stroke and Alzheimer’s, While Nitya Ray, Ph.D. is Named CytoDyn’s New COO to Lead CMC and Regulatory Operations Specifically the BLA for HIV
https://www.cytodyn.com/newsroom/press-releases/detail/564/cytodyn-names-chris-recknor-m-d-senior-executive-vp-of

CytoDyn Announces Study to Evaluate Potential Synergistic Effects of Leronlimab with Immune Checkpoint Blockade (ICB)
https://www.cytodyn.com/newsroom/press-releases/detail/565/cytodyn-announces-study-to-evaluate-potential-synergistic

CytoDyn Announces Legal Actions Against its Former CRO, Amarex Clinical Research
https://www.cytodyn.com/newsroom/press-releases/detail/563/cytodyn-announces-legal-actions-against-its-former-cro

PRER14A: Preliminary revised proxy soliciting materials
https://ir.stockpr.com/cytodyn/sec-filings-email/content/0001193125-21-293504/d246474dprer14a.htm


My comments are just my opinions and should NOT be taken as investment advice.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News